With BIT if isn’t as much about how the drug but the fact that it is unapproved and at phase 2. So basically it’s at the point where you ask how much and when to take it, you get ‘well according to that petri dish’ rather than ‘according to that study’. Does it have side effects? Don’t know. Can you take with other medications? Don’t know. It isn’t even at the point of mass production. Vaccination creation is also a very different science to drug testing and creation. It is more likely that this event may get them faster funding into phase 3 with corona virus as a focus, which would be good news should there be future outbreaks. For it’s use in current outbreak at most it can be a part of the phase 3 trial, which should include a few hundred to a thousand patients. Even with WHO’s approval, there may only be enough for say treatment in Australia.
